Suppr超能文献

简化膀胱训练对接受索利那新灵活剂量方案治疗的膀胱过度活动症患者的疗效:一项随机研究的结果。

Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study.

机构信息

Department of Urology, University Hospital, Lund, Sweden.

出版信息

BJU Int. 2010 Apr;105(8):1126-35. doi: 10.1111/j.1464-410X.2009.08910.x. Epub 2009 Oct 10.

Abstract

OBJECTIVE

To compare the efficacy of flexible-dose solifenacin 5/10 mg with and without simplified bladder training in patients with overactive bladder (OAB) syndrome.

PATIENTS AND METHODS

SOLAR (SOLifenacin Alone and with simplified bladder Re-training) was a multicentre, prospective, randomized, parallel-group, open-label study in patients with OAB. After a 2-week, single-blind, placebo run-in, 643 patients were randomized to treatment with either solifenacin 5 mg once daily (od) alone (323) or 5 mg od combined with simplified bladder training (320) for 8 weeks. At week 8, patients in both groups could request a dose increase to solifenacin 10 mg od for the remaining 8 weeks of the study. The primary efficacy endpoint was the change from baseline in the mean number of micturitions/24 h after 8 weeks. Secondary efficacy measures were the change in micturition frequency and other voiding diary variables at week 16. Patient-reported outcomes were also assessed, including patient Perception of Bladder Condition, Incontinence Quality of Life, and Treatment Satisfaction using a visual analogue scale score; tolerability was also assessed.

RESULTS

Solifenacin given alone was effective in improving all measures of OAB evaluated in the study. When simplified bladder training was used combined with solifenacin there was a further significant improvement in micturition frequency at week 8, and this difference was maintained through to week 16. The use of simplified bladder training with solifenacin also significantly improved treatment satisfaction at week 16 over the responses to solifenacin given alone. There was no significant difference between the treatment groups at week 16 in urgency, incontinence or other secondary variables measured. The most common adverse event reported was dry mouth in both treatment groups; there was a low rate of discontinuation due to adverse events in the total study group.

CONCLUSION

Combined treatment with solifenacin and simplified bladder training was more effective than solifenacin alone in reducing micturition frequency at weeks 8 and 16, and improving treatment satisfaction at week 16 in patients with OAB. Simplified bladder training did not improve on the benefits of solifenacin alone in the symptoms of urgency or incontinence.

摘要

目的

比较不同剂量索利那新(5/10mg)联合简化膀胱训练治疗膀胱过度活动症(OAB)的疗效。

方法

SOLAR(索利那新单独治疗与联合简化膀胱再训练)是一项多中心、前瞻性、随机、平行分组、开放标签研究,纳入 OAB 患者。经过为期 2 周的单盲、安慰剂导入期后,643 例患者被随机分配至索利那新 5mg 每日 1 次(qd)单药治疗组(n=323)或 5mg qd 联合简化膀胱训练组(n=320),治疗 8 周。第 8 周时,两组患者均可以要求增加剂量至索利那新 10mg qd,继续治疗 8 周。主要疗效终点为治疗 8 周后平均 24 小时排尿次数的变化。次要疗效指标为第 16 周时排尿频率及其他排尿日记变量的变化。还评估了患者报告的结局,包括使用视觉模拟评分(VAS)评估患者对膀胱状况的感知、尿失禁生活质量和治疗满意度;同时还评估了治疗的耐受性。

结果

索利那新单药治疗可有效改善研究中评估的所有 OAB 指标。当简化膀胱训练与索利那新联合应用时,第 8 周时排尿频率进一步显著改善,且这种差异一直持续到第 16 周。与单独使用索利那新相比,第 16 周时联合治疗还显著提高了患者的治疗满意度。第 16 周时,两组在尿急、失禁或其他次要变量方面无显著差异。在两个治疗组中,最常见的不良事件是口干,且总研究人群中因不良事件而停药的比例较低。

结论

与索利那新单药治疗相比,联合应用索利那新和简化膀胱训练可更有效降低 OAB 患者的排尿频率,提高治疗第 16 周时的治疗满意度。简化膀胱训练并不能提高索利那新单药治疗对尿急或失禁症状的疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验